<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.loc.gov/METS/ https://www.loc.gov/standards/mets/mets.xsd" OBJID="oai:wwu.de:bfa6bbc6-198e-43b7-97d6-b635131a2eeb" LABEL="University of Muenster, Institutional Repository MIAMI"  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
          <mets:metsHdr CREATEDATE="2022-11-09T14:52:29">
            <mets:agent TYPE="OTHER" ROLE="OTHER" OTHERTYPE="SOFTWARE">
              <mets:name>Memory Alpha</mets:name>
            </mets:agent>
          </mets:metsHdr>
          <mets:dmdSec ID="DMD_bfa6bbc6-198e-43b7-97d6-b635131a2eeb">
            <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
              <mets:xmlData>
                <mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd" version="3.7">
                  <mods:titleInfo type="uniform" lang="eng">
                    <mods:title script="Latn">Development of translational optical imaging strategies to assess inflammatory biomarkers in rheumatoid arthritis</mods:title>
                  </mods:titleInfo>
                  <mods:name type="personal" valueURI="http://d-nb.info/gnd/1174918705" altRepGroup="0">
                    <mods:namePart type="given">Mitchell J.</mods:namePart>
                    <mods:namePart type="family">Duffy</mods:namePart>
                    <mods:namePart type="date">1990-</mods:namePart>
                    <mods:displayForm>Duffy, Mitchell J.</mods:displayForm>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">aut</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="personal" valueURI="http://d-nb.info/gnd/1174918705" altRepGroup="0">
                    <mods:namePart type="given">Mitchell James</mods:namePart>
                    <mods:namePart type="family">Duffy</mods:namePart>
                    <mods:namePart type="date">1990-</mods:namePart>
                    <mods:displayForm>Duffy, Mitchell James</mods:displayForm>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">aut</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="personal" valueURI="http://d-nb.info/gnd/114976449">
                    <mods:namePart type="given">Michael</mods:namePart>
                    <mods:namePart type="family">Schäfers</mods:namePart>
                    <mods:namePart type="date">1967-</mods:namePart>
                    <mods:displayForm>Schäfers, Michael</mods:displayForm>
                    <mods:affiliation>FB 05: Medizinische Fakultät</mods:affiliation>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">ths</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Universitäts- und Landesbibliothek Münster</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>ULB Münster</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Landesbibliothek Münster / Universitäts- und Landesbibliothek Münster</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Universität Münster / Universitäts- und Landesbibliothek</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:genre>doctoralThesis</mods:genre>
                  <mods:genre authority="dct">Text</mods:genre>
                  <mods:originInfo>
                    <mods:dateIssued keyDate="yes">2018</mods:dateIssued>
                    <mods:dateOther>2018-11-28</mods:dateOther>
                    <mods:issuance>monographic</mods:issuance>
                  </mods:originInfo>
                  <mods:originInfo>
                    <mods:dateIssued encoding="w3cdtf">2019-01-08</mods:dateIssued>
                    <mods:dateModified encoding="w3cdtf">2019-01-08</mods:dateModified>
                    <mods:edition>[Electronic ed.]</mods:edition>
                  </mods:originInfo>
                  <mods:language>
                    <mods:languageTerm type="code" authority="iso639-2b">eng</mods:languageTerm>
                  </mods:language>
                  <mods:physicalDescription>
                    <mods:form>electronic</mods:form>
                    <mods:reformattingQuality>access</mods:reformattingQuality>
                    <mods:internetMediaType>application/pdf</mods:internetMediaType>
                    <mods:digitalOrigin>born digital</mods:digitalOrigin>
                  </mods:physicalDescription>
                  <mods:abstract lang="ger">&lt;p&gt;Rheumatoide Arthritis (RA) ist eine progredient verlaufende Autoimmunerkrankung. Charakteristisch für die Erkrankung sind entzündliche Schübe einhergehend mit einer Synovitis, sowie einer chronischen Knorpel-/ Knochendegeneration. Zur Verringerung der krankheitsbedingten Morbidität, sind die Früherkennung und eine genaue Therapieüberwachung elementar. Ziel der Arbeit war die nicht invasive Darstellung der entzündlichen Schlüsselproteine S100A8/9 und MMPs mittels nicht-invasiver Fluoreszenz Reflektanz Bildgebung. Beide Biomarker wurden im RA Tiermodell zu Beginn und während der Resolutionsphase der Entzündung mittels Bildgebung untersucht. Beide Signale waren zu Beginn der Entzündung erhöht und fielen während der Resolutionsphase ab. Veränderungen im klinischen Scoring wurden vor Veränderungen der Biomarker beobachtet. Es wurden erstmals zwei neuartige Tracer basierend auf kleinen Molekülen zur nicht-invasiven, longitudinalen Darstellung wichtiger Entzündungsbiomarker der RA angewendet.&lt;/p&gt;</mods:abstract>
                  <mods:abstract lang="eng">&lt;p&gt;Rheumatoid Arthritis (RA) is a progressive and debilitating autoimmune disease characterized by repeated inflammatory flares, synovitis, as well as cartilage and bone destruction. Early recognition and subsequent treatment monitoring of a flare are key to reducing RA morbidity. To this end, we applied Fluorescence Reflectance Imaging (FRI) in a study of the onset and resolution phases of the Collagen Induced Arthritis (CIA) model of RA, monitoring the biomarkers S100A8/9, an initiator of inflammatory response, and Matrix-metalloproteinases (MMPs), enzymes implicated in cartilage and bone destruction as well as tissue remodeling. Signals of both proteins increased and decreased in concert, with an  increase in clinical score preceding the biomarkers. For the first time, small molecule tracers targeting S100A8/A9 and MMPs were used simultaneously, longitudinally, to assess inflammatory activity using optical, non-invasive molecular imaging techniques in a model of RA.&lt;/p&gt;</mods:abstract>
                  <mods:tableOfContents lang="eng">1 Abstract 1&#13;
2 Introduction 2&#13;
2.1 Rheumatoid Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2&#13;
2.1.1 Causes of Rheumatoid Arthritis . . . . . . . . . . . . . . . . . . . . . 2&#13;
2.1.2 Inflammation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3&#13;
2.1.3 Cartilage and Bone Destruction . . . . . . . . . . . . . . . . . . . . . 3&#13;
2.1.4 Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5&#13;
2.1.4.1 Laboratory Values . . . . . . . . . . . . . . . . . . . . . . . 6&#13;
2.1.5 Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7&#13;
2.1.6 Role of Imaging in Arthritis . . . . . . . . . . . . . . . . . . . . . . . 8&#13;
2.2 Imaging Modalities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9&#13;
2.3 Optical Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10&#13;
2.3.1 Fluorescence Reflectance Imaging . . . . . . . . . . . . . . . . . . . . 10&#13;
2.4 Biomarkers for imaging of inflammation in RA . . . . . . . . . . . . . . . . . 16&#13;
2.4.1 S100A9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16&#13;
2.4.1.1 Structure and Function . . . . . . . . . . . . . . . . . . . . . 16&#13;
2.4.1.2 Role of S100A8/A9 in RA . . . . . . . . . . . . . . . . . . . 17&#13;
2.4.1.2.1 Initiation and Leukocyte Invasion . . . . . . . . . . 17&#13;
2.4.1.2.2 Cartilage and Bone Destruction . . . . . . . . . . . 18&#13;
2.4.1.3 Imaging Strategies for S100 alarmins . . . . . . . . . . . . . 18&#13;
2.4.2 Matrix Metalloproteinases . . . . . . . . . . . . . . . . . . . . . . . . 19&#13;
2.4.2.1 Structure and Function . . . . . . . . . . . . . . . . . . . . . 19&#13;
2.4.2.2 Role of MMPs in RA . . . . . . . . . . . . . . . . . . . . . . 20&#13;
2.4.2.2.1 Inflammation, Invasion and Synovitis . . . . . . . . 20&#13;
2.4.2.2.2 Remodelling and Degradation . . . . . . . . . . . . 21&#13;
2.4.2.3 Imaging strategies for MMP activity . . . . . . . . . . . . . 22&#13;
2.5 Animal Models of Rheumatoid Arthritis . . . . . . . . . . . . . . . . . . . . 22&#13;
3 Aim 25&#13;
4 Materials and Methods 26&#13;
4.1 Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26&#13;
4.1.1 Fluorescent labels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26&#13;
4.1.2 Chemicals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26&#13;
4.1.3 Consumables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27&#13;
4.1.4 Antibodies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27&#13;
4.1.4.1 Primary Antibodies . . . . . . . . . . . . . . . . . . . . . . . 27&#13;
4.1.4.2 Secondary Antibodies . . . . . . . . . . . . . . . . . . . . . 27&#13;
4.1.5 Equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27&#13;
4.1.6 Software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28&#13;
4.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28&#13;
4.2.1 Mice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28&#13;
4.2.2 Collagen-induced arthritis (CIA) . . . . . . . . . . . . . . . . . . . . 28&#13;
4.2.3 FRI Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29&#13;
4.2.4 Imaging Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29&#13;
4.2.5 Immunohistochemistry . . . . . . . . . . . . . . . . . . . . . . . . . . 29&#13;
4.2.5.1 H&amp;E staining . . . . . . . . . . . . . . . . . . . . . . . . . . 30&#13;
4.2.5.2 Immunofluorescence Staining . . . . . . . . . . . . . . . . . 30&#13;
4.2.5.3 Mac-3 / MRP14 Double Staining Immunofluorescence . . . . 31&#13;
4.2.6 Statistical Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31&#13;
4.2.7 Experimental Setup . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32&#13;
4.2.7.1 Onset group . . . . . . . . . . . . . . . . . . . . . . . . . . . 32&#13;
4.2.7.2 Resolution group . . . . . . . . . . . . . . . . . . . . . . . . 32&#13;
5 Results 33&#13;
5.1 Onset phase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34&#13;
5.1.1 Imaging results show individual inflammation of paws in CIA . . . . 34&#13;
5.1.2 Two subtypes of disease progression identified . . . . . . . . . . . . . 34&#13;
5.1.3 Both fast and slow responders show statistically elevated S100A8/A9&#13;
and MMP levels on the day of peak inflammation . . . . . . . . . . . 36&#13;
5.1.4 S100A8/A9 and MMP SBRs correlate and are elevated in paws with&#13;
high clinical scores . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36&#13;
5.2 Resolution phase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36&#13;
5.2.1 Imaging results show inflammation resolution and low SBRs at late&#13;
time point regardless of paw clenching . . . . . . . . . . . . . . . . . 36&#13;
5.2.2 Imaging of the resolution of a highly inflamed state shows decreasing&#13;
levels of inflammatory biomarkers. . . . . . . . . . . . . . . . . . . . . 37&#13;
5.3 Histology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39&#13;
5.3.1 Morphological findings . . . . . . . . . . . . . . . . . . . . . . . . . . 39&#13;
5.3.2 Immunohistochemistry corroborates target presence beginning at clinical&#13;
score 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41&#13;
5.3.3 Late stage disease shows little S100A8/A9 and MMP expression despite&#13;
high clinical scores . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41&#13;
5.3.4 Single joint inflammation case study . . . . . . . . . . . . . . . . . . 41&#13;
5.4 Analysis Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42&#13;
5.4.1 Why employ the signal to background ratio? . . . . . . . . . . . . . . 42&#13;
5.4.2 Thresholded SBR Inflammatory Area Analysis Method . . . . . . . . 45&#13;
5.4.3 Thresholded SBR Inflammatory Fraction Analysis Method . . . . . . 45&#13;
5.4.4 Receiver Operating Characteristic for optimal threshold determination 45&#13;
6 Discussion 49&#13;
6.1 Multiplexing small molecule probes provided novel insight into concurrent&#13;
expression of MMPs and S100A8/A9 . . . . . . . . . . . . . . . . . . . . . . 49&#13;
6.2 No time shift between the expression of S100A8/A9 and MMPs was found . 50&#13;
6.3 Histology corroborated S100A9 and MMP-9 imaging data . . . . . . . . . . . 51&#13;
6.4 Division of onset phase CIA mice into fast and slow responding groups . . . 52&#13;
6.5 The clinical score reflects externally observable markers of inflammation . . . 53&#13;
6.6 Choice of analysis method and use of signal to background ratio . . . . . . . 54&#13;
6.7 Blood concentration of tracer is lower in CIA mice . . . . . . . . . . . . . . . 55&#13;
6.8 Thresholded SBR Area and Fraction analyses considered . . . . . . . . . . . 55&#13;
6.9 ROC curves indicate limited applicability of thresholding methods . . . . . . 56&#13;
6.10 FRI in the clinic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57&#13;
6.11 Photoacoustic imaging of Naphthalocyanine labelled ligands presents a 3D&#13;
diagnostic opportunity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57&#13;
7 Conclusions and Outlook 60&#13;
References I&#13;
Appendix XVII&#13;
A Abbreviations XVII&#13;
B List of Figures XXI&#13;
C List of Tables XXI&#13;
D Acknowledgements XXII&#13;
E Curriculum Vitae XXV</mods:tableOfContents>
                  <mods:targetAudience>specialized</mods:targetAudience>
                  <mods:subject>
                    <mods:topic lang="ger">Rheumatoide Arthritis; S100A9; Matrix-Metalloproteasen; Fluoreszenz Reflektanz Bildgebung; Molekulare Bildgebung; Kollagen-induzierte Arthritis</mods:topic>
                  </mods:subject>
                  <mods:subject>
                    <mods:topic lang="eng">Rheumatoid Arthritis; S100A9; Matrix-Metalloproteinase; Fluorescence Reflectance Imaging; Molecular Imaging; Collagen Induced Arthritis</mods:topic>
                  </mods:subject>
                  <mods:classification authority="ddc">570</mods:classification>
                  <mods:identifier type="urn">urn:nbn:de:hbz:6-66129611842</mods:identifier>
                  <mods:location>
                    <mods:url access="object in context">https://miami.uni-muenster.de/Record/bfa6bbc6-198e-43b7-97d6-b635131a2eeb</mods:url>
                  </mods:location>
                  <mods:accessCondition type="use and reproduction">
                    <mods:extension>
                      <ma:maWrap xmlns:ma="http://memoryalpha.ulb.uni-muenster.de">
                        <ma:licence>
                          <ma:displayLabel>InC 1.0</ma:displayLabel>
                          <ma:targetUrl>https://rightsstatements.org/vocab/InC/1.0/</ma:targetUrl>
                        </ma:licence>
                      </ma:maWrap>
                    </mods:extension>
                  </mods:accessCondition>
                  <mods:recordInfo>
                    <mods:recordIdentifier>oai:wwu.de:bfa6bbc6-198e-43b7-97d6-b635131a2eeb</mods:recordIdentifier>
                  </mods:recordInfo>
                </mods:mods>
              </mets:xmlData>
            </mets:mdWrap>
          </mets:dmdSec>
          <mets:amdSec ID="AMD_bfa6bbc6-198e-43b7-97d6-b635131a2eeb">
            <mets:rightsMD ID="RIGHTSMD_bfa6bbc6-198e-43b7-97d6-b635131a2eeb">
              <mets:mdWrap MDTYPE="OTHER" MIMETYPE="text/xml" OTHERMDTYPE="DVRIGHTS">
                <mets:xmlData>
                  <dv:rights xmlns:dv="http://dfg-viewer.de/">
                    <dv:owner>Universitäts- und Landesbibliothek Münster</dv:owner>
                  </dv:rights>
                </mets:xmlData>
              </mets:mdWrap>
            </mets:rightsMD>
            <mets:digiprovMD ID="DIGIPROVMD_bfa6bbc6-198e-43b7-97d6-b635131a2eeb">
              <mets:mdWrap MDTYPE="OTHER" MIMETYPE="text/xml" OTHERMDTYPE="DVLINKS">
                <mets:xmlData>
                  <dv:links xmlns:dv="http://dfg-viewer.de/">
                    <dv:reference>https://miami.uni-muenster.de/Record/bfa6bbc6-198e-43b7-97d6-b635131a2eeb</dv:reference>
                    <dv:presentation/>
                  </dv:links>
                </mets:xmlData>
              </mets:mdWrap>
            </mets:digiprovMD>
          </mets:amdSec>
          <mets:fileSec>
            <mets:fileGrp USE="DEFAULT">
              <mets:file MIMETYPE="application/pdf" CHECKSUM="f05ba68fd9f09820f52e5667b1a867cb2fb5ce17224cc543a41d0763ec70c483" CREATED="2019-01-08T11:24:19" CHECKSUMTYPE="SHA-256" SIZE="50443914" ID="ID_FIL_diss_duffy.pdf_DEFAULT">
                <mets:FLocat xlink:href="https://repositorium.uni-muenster.de/document/miami/bfa6bbc6-198e-43b7-97d6-b635131a2eeb/diss_duffy.pdf" LOCTYPE="URL"/>
              </mets:file>
            </mets:fileGrp>
            <mets:fileGrp USE="DOWNLOAD">
              <mets:file MIMETYPE="application/pdf" ID="DOWbfa6bbc6-198e-43b7-97d6-b635131a2eeb">
                <mets:FLocat xlink:href="https://repositorium.uni-muenster.de/transfer/miami/bfa6bbc6-198e-43b7-97d6-b635131a2eeb" LOCTYPE="URL"/>
              </mets:file>
            </mets:fileGrp>
          </mets:fileSec>
          <mets:structMap TYPE="PHYSICAL">
            <mets:div ID="ID_PHY_bfa6bbc6-198e-43b7-97d6-b635131a2eeb" TYPE="physSequence">
              <mets:div ID="ID_PHY_diss_duffy.pdf">
                <mets:fptr FILEID="ID_FIL_diss_duffy.pdf_DEFAULT"/>
              </mets:div>
            </mets:div>
          </mets:structMap>
          <mets:structMap TYPE="LOGICAL">
            <mets:div ADMID="AMD_bfa6bbc6-198e-43b7-97d6-b635131a2eeb" DMDID="DMD_bfa6bbc6-198e-43b7-97d6-b635131a2eeb" ID="ID_LOG_bfa6bbc6-198e-43b7-97d6-b635131a2eeb" TYPE="Monograph">
              <mets:div ID="ID_LOG_ID_PHY_diss_duffy.pdf"/>
            </mets:div>
          </mets:structMap>
          <mets:structLink>
            <mets:smLink xlink:from="ID_LOG_bfa6bbc6-198e-43b7-97d6-b635131a2eeb" xlink:to="ID_PHY_bfa6bbc6-198e-43b7-97d6-b635131a2eeb"/>
            <mets:smLink xlink:from="ID_LOG_ID_PHY_diss_duffy.pdf" xlink:to="ID_PHY_diss_duffy.pdf"/>
          </mets:structLink>
        </mets:mets>